Association of Fungal Isolates with In-Hospital Mortality in Patients with COVID-19: A Retrospective Cohort Study

Fungal co-infections are increasingly reported in hospitalized COVID-19 patients; but their clinical significance remains uncertain. We conducted a retrospective cohort study of 3373 hospitalized patients with COVID-19 to evaluate the association between fungal isolates and in-hospital mortality. Fungal isolates were identified in 197 (5.8%) patients, predominantly from respiratory specimens, with non-albicans Candida species accounting for most isolates. Patients with fungal isolates were older, had longer hospital stays, and exhibited higher rates of comorbidities, intensive care use, and exposure to broad-spectrum antibiotics, corticosteroids, and tocilizumab. In-hospital mortality was higher among patients with fungal isolates (18.8% vs. 12.2%, p=0.009). However, in multivariable logistic regression analysis, fungal isolates were not independently associated with mortality (adjusted OR 1.49, 95% CI 0.97-2.29). Mortality was independently associated with age, chronic kidney disease, immunosuppression, and treatment-related factors. These findings suggest that fungal isolates are more likely markers of disease severity and treatment exposure rather than direct contributors to mortality.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-18
DOI
https://doi.org/10.20944/preprints202611.1844.v1
Primary Topic
Antifungal resistance and susceptibility
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Association of Fungal Isolates with In-Hospital Mortality in Patients with COVID-19: A Retrospective Cohort Study

Ajete Aliu-Bejta, Lindita Ajazaj Berisha, Donjeta Hajdari, Ilir Bejta
Preprints.org
Antifungal resistance and susceptibility
preprint

Association of Fungal Isolates with In-Hospital Mortality in Patients with COVID-19: A Retrospective Cohort Study

Ajete Aliu-Bejta, Lindita Ajazaj Berisha, Donjeta Hajdari, Ilir Bejta
preprint en

Abstract

Fungal co-infections are increasingly reported in hospitalized COVID-19 patients; but their clinical significance remains uncertain. We conducted a retrospective cohort study of 3373 hospitalized patients with COVID-19 to evaluate the association between fungal isolates and in-hospital mortality. Fungal isolates were identified in 197 (5.8%) patients, predominantly from respiratory specimens, with non-albicans Candida species accounting for most isolates. Patients with fungal isolates were older, had longer hospital stays, and exhibited higher rates of comorbidities, intensive care use, and exposure to broad-spectrum antibiotics, corticosteroids, and tocilizumab. In-hospital mortality was higher among patients with fungal isolates (18.8% vs. 12.2%, p=0.009). However, in multivariable logistic regression analysis, fungal isolates were not independently associated with mortality (adjusted OR 1.49, 95% CI 0.97-2.29). Mortality was independently associated with age, chronic kidney disease, immunosuppression, and treatment-related factors. These findings suggest that fungal isolates are more likely markers of disease severity and treatment exposure rather than direct contributors to mortality.

Preprints.org
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon